The Voice of Rare Disease
Patients in Europe
List of the latest marketing authorisations and orphan medicinal products designations
Detailed information on European orphan medicinal products designation applications is available on the EMA website. A full list of designated and authorised orphan medicinal products in Europe available at: ec.europa.eu.
Learn more about the Orphan designation process in Europe
Recent marketing authorisations
Medicinal Product | Marketing Authorisation Holder | Therapeutic Indication | Date of Marketing Authorisation | |
Cystadrops® (mercaptamine) | Orphan Europe S.A.R.L. | Cystinosis | 19/01/2017 | |
Ledaga® (chlormethine) | Actelion Registration Ltd. |
T-cell lymphoma | 03/03/2017 | |
(parathyroid hormone) | Shire Pharmaceuticals Ireland Ltd | Hypoparathyroidism | 24/04/2017 |
*Removed from the Community register of orphan medicinal products upon request of the MAH at the time of marketing authorisation
.png)
No hay comentarios:
Publicar un comentario